News

Explore Our Free-Market Analysis Sample – Instant Access: – https://www.astuteanalytica.com/request-sample/amyotrophic-lateral-sclerosis-treatment-market ...
US FDA grants orphan drug designation to Klotho Neurosciences’ KLTO-202 to treat amyotrophic lateral sclerosis: New York Saturday, July 12, 2025, 15:00 Hrs [IST] Klotho Neurosci ...
Stem cell tech simulates ALS, quantum tools decode quasicrystals, and cancer exploits a human mutation—three breakthroughs ...
In a powerful act of compassion and community, Starr’s Mill High School organized an early graduation for rising senior ...
A coalition of ALS patients and caregivers is petitioning the FDA to review available data on the stem cell therapy NurOwn ...
Detailed price information for Klotho Neurosciences Inc (KLTO-Q) from The Globe and Mail including charting and trades.
BrainStorm Cell Therapeutics issued a statement Tuesday supporting a Citizens’ Petition submitted to the FDA requesting the ...
Brain-machine interfaces (BMIs) are becoming lifelines for people facing severe motor impairments. For many individuals with ...
In 2023, Chantler took it upon himself to look for a specialized mobility device called a 'TrailRider' to rent for an outdoor ...
I am 87 — and proud of it! As proof of that, I plan on changing the photograph I have been using for years in my column. I ...
Neurizon Therapeutics has announced it has received positive feedback from the US Food and Drug Administration (FDA) on its ...
JJ Potrikus, vice president of the New York Collegiate Baseball League, joined Bridge Street for details this morning along ...